Your browser doesn't support javascript.
loading
FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection.
Sethi, Sanjeev; Madden, Benjamin; Casal Moura, Marta; Nasr, Samih H; Alexander, Mariam P; Debiec, Hanna; Torrel, Nate; Gross, LouAnn; Negron, Vivian; Specks, Ulrich; Fervenza, Fernando C; Haas, Mark; Ronco, Pierre; Batal, Ibrahim.
Afiliação
  • Sethi S; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA. Electronic address: sethi.sanjeev@mayo.edu.
  • Madden B; Mayo Clinic Proteomics Core, Mayo Clinic, Rochester, Minnesota, USA.
  • Casal Moura M; Division of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA; Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Nasr SH; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Alexander MP; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Debiec H; Sorbonne Université, Université Pierre et Marie Curie Paris 06, Paris, France; Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S 1155, Paris, France.
  • Torrel N; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Gross L; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Negron V; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Specks U; Division of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Fervenza FC; Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
  • Haas M; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Ronco P; Division of Nephrology, Centre Hospitalier du Mans, Le Mans, France.
  • Batal I; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
Kidney Int ; 106(5): 985-990, 2024 Nov.
Article em En | MEDLINE | ID: mdl-39181399

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article